LEMAITRE VASCULAR, INC. (LMAT) Operating cash flow 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$81.3MFY2025 · since FY2016: $16.9M → $81.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $81.3M | +84.1% |
| FY2024 | $44.1M | +20.1% |
| FY2023 | $36.8M | +44.8% |
| FY2022 | $25.4M | -27.7% |
| FY2021 | $35.1M | +0.9% |
| FY2020 | $34.8M | +145.4% |
| FY2019 | $14.2M | -27.3% |
| FY2018 | $19.5M | -14.7% |
| FY2017 | $22.9M | +35.3% |
| FY2016 | $16.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Net marginLMAT Gross profitLMAT Gross marginLMAT Operating incomeLMAT Operating marginLMAT Free cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Total liabilitiesLMAT Shareholders’ equityLMAT overview →